These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33714654)

  • 41. The Potential Contribution of Supplementary Immunization Activities to Routine Immunization in Kebbi State, Nigeria.
    Omoleke SA; Getachew B; Igoh CS; Yusuf TA; Lukman SA; Loveday N
    J Prim Care Community Health; 2020; 11():2150132720932698. PubMed ID: 32508212
    [No Abstract]   [Full Text] [Related]  

  • 42. A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data.
    Wariri O; Nkereuwem E; Erondu NA; Edem B; Nkereuwem OO; Idoko OT; Agogo E; Enegela JE; Sesay T; Conde IS; Kaucley L; Awuah AA; Abdullahi S; Luce RR; Banda R; Nomhwange T; Kampmann B
    Lancet Glob Health; 2021 Mar; 9(3):e280-e290. PubMed ID: 33607028
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implementing nationwide measles supplemental immunization activities in Ethiopia in the context of COVID-19: process and lessons learnt.
    Nigus M; Zelalem M; Abraham K; Shiferaw A; Admassu M; Masresha B
    Pan Afr Med J; 2020; 37(Suppl 1):36. PubMed ID: 33456660
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.
    Sowe A; Njie M; Sowe D; Fofana S; Ceesay L; Camara Y; Tesfaye B; Bah S; Bah AK; Baldeh AK; Dampha BD; Baldeh SN; Touray A
    PLoS One; 2021; 16(10):e0258961. PubMed ID: 34673828
    [TBL] [Abstract][Full Text] [Related]  

  • 45. World Health Organization's Innovative Direct Disbursement Mechanism for Payment of Grassroots Immunization Personnel and Operations in Nigeria: 2004-2015.
    Yehualashet YG; Wadda A; Agblewonu KB; Zhema T; Ibrahim AA; Corr A; Linkins J; Mkanda P; Vaz RG; Nsubuga P; Ashogbon D
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S108-15. PubMed ID: 26908746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polio Legacy in Action: Using the Polio Eradication Infrastructure for Measles Elimination in Nigeria-The National Stop Transmission of Polio Program.
    Michael CA; Waziri N; Gunnala R; Biya O; Kretsinger K; Wiesen E; Goodson JL; Esapa L; Gidado S; Uba B; Nguku P; Cochi S
    J Infect Dis; 2017 Jul; 216(suppl_1):S373-S379. PubMed ID: 28838182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
    Fu H; Abbas K; Klepac P; van Zandvoort K; Tanvir H; Portnoy A; Jit M
    BMC Med; 2021 Nov; 19(1):281. PubMed ID: 34784922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An evaluation of the 2012 measles mass vaccination campaign in Guinea.
    Doumtsop JG; Malano ER; Diallo IT; Sirimah C
    Pan Afr Med J; 2014; 17():4. PubMed ID: 25184021
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improving immunization capacity in Ethiopia through continuous quality improvement interventions: a prospective quasi-experimental study.
    Manyazewal T; Mekonnen A; Demelew T; Mengestu S; Abdu Y; Mammo D; Abebe W; Haffa B; Zenebe D; Worku B; Aman A; Tigabu S
    Infect Dis Poverty; 2018 Nov; 7(1):119. PubMed ID: 30497515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria.
    Peter KB; Ademola AS; Oyeku OA
    Afr Health Sci; 2014 Mar; 14(1):131-5. PubMed ID: 26060469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of engaging communities in decision-making and action through traditional and religious leaders on vaccination coverage in Cross River State, Nigeria: A cluster-randomised control trial.
    Oyo-Ita A; Bosch-Capblanch X; Ross A; Oku A; Esu E; Ameh S; Oduwole O; Arikpo D; Meremikwu M
    PLoS One; 2021; 16(4):e0248236. PubMed ID: 33861742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implementation of the World's largest measles-rubella mass vaccination campaign in Bangladesh: a process evaluation.
    Sarma H; Budden A; Luies SK; Lim SS; Shamsuzzaman M; Sultana T; Rajaratnam JK; Craw L; Banwell C; Ali MW; Uddin MJ
    BMC Public Health; 2019 Jul; 19(1):925. PubMed ID: 31291922
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nationwide measles supplementary immunization activities to increase immunity levels in Nigeria.
    Jean Baptiste AE; Bawa S; Oteri AJ; Dieng B; Shuaib F; Mulombo WK
    Vaccine; 2021 Nov; 39 Suppl 3():C1-C2. PubMed ID: 34531080
    [No Abstract]   [Full Text] [Related]  

  • 54. Impact of a measles immunisation campaign on measles admissions to a Natal hospital.
    Abdool Karim SS; Abdool Karim Q; Chamane M
    S Afr Med J; 1991 Dec; 80(11-12):579-81. PubMed ID: 1745947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunisation coverage and its determinants among children aged 12-23 months in Atakumosa-west district, Osun State Nigeria: a cross-sectional study.
    Adedire EB; Ajayi I; Fawole OI; Ajumobi O; Kasasa S; Wasswa P; Nguku P
    BMC Public Health; 2016 Aug; 16(1):905. PubMed ID: 27578303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First 5 years of measles elimination in southern Africa: 1996-2000.
    Biellik R; Madema S; Taole A; Kutsulukuta A; Allies E; Eggers R; Ngcobo N; Nxumalo M; Shearley A; Mabuzane E; Kufa E; Okwo-Bele JM
    Lancet; 2002 May; 359(9317):1564-8. PubMed ID: 12047966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measles high school vaccination program, 2014-2015: online survey of parents in NSW, Australia.
    Nicholl S; Seale H; Campbell-Lloyd S
    Public Health Res Pract; 2018 Jun; 28(2):. PubMed ID: 29925088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How can the use of data within the immunisation programme be increased in order to improve data quality and ensure greater accountability in the health system? A protocol for implementation science study.
    Tilahun B; Teklu A; Mancuso A; Abebaw Z; Dessie K; Zegeye D
    Health Res Policy Syst; 2018 May; 16(1):37. PubMed ID: 29724235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.